Executives provided updates on their companies at the 35th Annual JP Morgan Healthcare Conference in San Francisco, CA, Day Two
The company also announced a 5 percent increase in preliminary fourth quarter revenues, to $619 million and above analysts' estimates.
The firm expects full-year revenue growth of up to 39 percent, but fell short of prior guidance for the year.
Executives from Genomic Health, Meridian Bioscience, and Qiagen provided updates on their companies at the JP Morgan Healthcare Conference in San Francisco.
Developers said Illumina's decision to tap into the cancer screening market is not surprising because of its potentially huge size.
Executives from Luminex, Exact Sciences, T2 Biosystems, and Singulex provided updates on their companies' businesses on the final day of the conference.
Executives from several life science research tool and diagnostic firms provided conference attendees with updates on their businesses.
The chemistry will be single-molecule, based on hybridization, and will not require amplification, enzymes, or library prep, the firm said.
MedCity News says the real highlight of the JP Morgan Healthcare conference was when 23andMe CEO Anne Wojcicki was shushed for talking during her own company's presentation.
Executives from Thermo Fisher Scientific, Qiagen, Danaher, Counsyl, Human Longevity, and Adaptive Biotechnologies provided business updates to conference goers.
US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.
Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.
Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.
In Science this week: almond reference genome, and more.